Evaluation of the Efficacy of a Coordinated Interprofessional Care Pathway on Disability in Patients With Chronic and at Risk of Chronic Low Back Pain in Primary Care
Launched by CNGE CONSEIL · Sep 5, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with low back pain by improving teamwork between doctors and physiotherapists. Low back pain is a common problem that can seriously affect people's lives, which is why it’s important to find better ways to manage it. The study aims to see if working together more closely can lead to better outcomes for patients, especially for those who might be at risk of their pain becoming a long-term issue.
To participate in the trial, you need to be an adult between 18 and 65 years old, and have either a new episode of low back pain or recurring pain that could become chronic. You should also be fluent in French and able to give your consent after learning about the study. If you join, you can expect to receive coordinated care from both your doctor and physiotherapist, which may help improve your condition. It’s worth noting that some people, like those who are pregnant or have serious health issues, won’t be eligible to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients between the ages of 18 and 65
- • Patients consulting their GP for a first or new eisode of acute low back pain (more than 12 months from the previous one) with a STarT Back screening tool score greater than 3.
- • OR low back pain at risk of chronicity (presence of yellow flags, according to the recommendation of the High Health Authority (HAS) of 2019
- • OR recurrent low back pain: in the event of recurrence of low back pain within 12 months after the previous episode, then considered to be at risk of chronicity
- • OR having chronic low back pain (low back pain for more than 3 months)
- • Patients benefiting from the general social security system
- • Patients who understand and speak French fluently
- • Patients who have given their consent after having received complete information on the protocol
- Exclusion Criteria:
- • Minor patients
- • Pregnant women (declared pregnancy) or immediately postpartum (up to 3 months)
- • Patients with "red flags" (serious neurological impairment, cancer, infection, fracture or inflammatory disease), according to the 2019 HAS recommendation
- • Patients referred immediately for imaging or specialist advice during the first consultation with the GP (suspicion of underlying pathology)
- • Patients with no history of acute low back pain, at low risk of chronicity (STarT Back screening tool score less than or equal to 3)
- • Patients with a contraindication to rehabilitation by physiotherapy
- • Patients who have already undergone spine surgery
- • Patients with cognitive impairment
- • Patients whose life expectancy is less than 12 months
- • Patients under guardianship or curatorship, under judicial protection or safeguard of justice
- • Patients not affiliated to the general social security system
- • Patients with difficulties in understanding the French language
- • Patients with an inability to give express consent
About Cnge Conseil
CNGE Conseil is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through strategic research and development. With a strong emphasis on collaboration and scientific excellence, CNGE Conseil specializes in designing and managing clinical trials across various therapeutic areas. Their team of experienced professionals is committed to ensuring compliance with regulatory standards while prioritizing patient safety and data integrity. By leveraging cutting-edge methodologies and a robust network of clinical sites, CNGE Conseil aims to expedite the development of new treatments, ultimately improving patient outcomes and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fontainebleau, , France
Patients applied
Trial Officials
Tan-Trung PHAN
Study Chair
Département Universitaire d'Enseignement et de Recherche en Médecine Générale - Université Paris-Est Créteil, 8 rue du Général Sarrail 94010 Créteil Cedex
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials